87 results
Page 3 of 5
10-K/A
umoi75y136l q7z6p0a
29 Apr 22
Annual report (amended)
4:43pm
PREC14A
sres9jpor0xs6e9c7ah
26 Apr 22
Preliminary proxy with contested solicitation
8:48am
PRRN14A
q0bkmppbl4pq3l3xzh7
25 Apr 22
Revised preliminary proxy statement filed by non-management
5:23pm
PREC14A
21kbwvuxo7d
11 Apr 22
Preliminary proxy with contested solicitation
6:44am
10-K
EX-10.11
96f5biizf ala
31 Mar 22
Annual report
8:18am
10-K
9iiydkxxo2u4ikjqk
31 Mar 22
Annual report
8:18am
8-K
EX-99.1
himq3ih
21 Mar 22
Departure of Directors or Certain Officers
6:32am
8-K/A
EX-99.1
usp7lyfnly25guozyk8
21 Mar 22
Departure of Directors or Certain Officers
6:30am
8-K
EX-99.1
w9423sdrs
13 Jan 22
Regulation FD Disclosure
8:01am
8-K
EX-99.1
zan9znbg h0
14 Dec 21
Adagio Therapeutics Reports Reduction in In Vitro Neutralizing Activity of ADG20 Against Omicron SARS-CoV-2 Variant
9:10am
8-K
EX-99.1
mxngj abchoffy7
29 Nov 21
Regulation FD Disclosure
8:23am
10-Q
EX-10.7
kfp9h
20 Sep 21
Quarterly report
4:17pm
10-Q
EX-10.5
goi8awwqzor6jc8xyi
20 Sep 21
Quarterly report
4:17pm
10-Q
oydeke5sm6 q95r
20 Sep 21
Quarterly report
4:17pm
10-Q
EX-10.6
wmgd10nd5dplag4v
20 Sep 21
Quarterly report
4:17pm
8-K
EX-3.2
ubpsrhh
10 Aug 21
Amendments to Articles of Incorporation or Bylaws
5:26pm
424B4
w3852ebysi3y8f
6 Aug 21
Prospectus supplement with pricing info
4:54pm